Supernus Pharmaceuticals
SUPN
#4268
Rank
C$2.59 B
Marketcap
$46.55
Share price
0.77%
Change (1 day)
3.39%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : C$0.47 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.47 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.47 B0.96%
2023-12-31C$0.47 B-57.35%
2022-12-31C$1.10 B-0.47%
2021-12-31C$1.11 B14.97%
2020-12-31C$0.96 B31.22%
2019-12-31C$0.73 B3.2%
2018-12-31C$0.71 B262.2%
2017-12-31C$0.19 B24.66%
2016-12-31C$0.15 B13.43%
2015-12-31C$0.13 B25.18%
2014-12-31C$0.11 B35.11%
2013-12-31C$82.53 M127.89%
2012-12-31C$36.21 M-19.61%
2011-12-31C$45.04 M-50.65%
2010-12-31C$91.29 M0.82%
2009-12-31C$90.54 M-11.22%
2008-12-31C$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$1.30 B 176.82%๐Ÿ‡บ๐Ÿ‡ธ USA
C$91.62 B 19,290.77%๐Ÿ‡บ๐Ÿ‡ธ USA
C$108.36 B 22,832.84%๐Ÿ‡บ๐Ÿ‡ธ USA
C$47.64 B 9,983.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$154.42 B 32,581.59%๐Ÿ‡บ๐Ÿ‡ธ USA